MarketPeel
Insider Trading Intelligence
Pricing
…
ES

Eugene Schneider

IONS
EVP, CHF CLINICAL DEVELOP OFCR · IONIS PHARMACEUTICALS INC · CIK 0001838539
FILING MIX · LIFETIME51%/49%
BUYS
33
SELLS
32
TOTAL VALUE
$12.43M
COMPANIES
1
ACTIVE SINCE
Jan 2021
HOLDINGS NOW
77,114
AVG SELL PX
$59.51
TRADE KIND
SHOWING 65 / 65
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 17 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Eugene Schneider, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+40.00%+1.74%+0.84%+0.90%+1.93%—
14d15+46.67%-0.91%+1.12%-2.03%-1.97%—
30d15+53.33%+1.58%+2.50%-0.92%-2.06%—
60d15+66.67%-0.71%+3.13%-3.85%-8.20%—
90d15+73.33%+0.97%+3.94%-2.97%-13.43%—
180d15(3 pending)+50.00%+16.62%+11.43%+5.19%-10.89%—
1y15(6 pending)+55.56%+18.77%+22.60%-3.82%-56.83%—
2y15(8 pending)+28.57%+36.19%+48.39%-12.20%+4.37%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IONS · 77,114 shares · as of Jun 26, 2026
025,77951,55777,336103,11420222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 33 buys / 32 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
26,000$81.05$2.11M77,114Jun 26, 2026Jun 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
26,000$60.89$1.58M103,114Jun 26, 2026Jun 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
26,000——26,000Jun 26, 2026Jun 30, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
5,812$70.97$412.5K63,890Mar 19, 2026Mar 23, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
6,179$83.45$515.6K69,702Jan 30, 2026Feb 2, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
11,991——75,881Jan 29, 2026Feb 2, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
9,302$75.59$703.1K63,890Jan 16, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
21,685——39,251Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
21,685——73,192Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,800——91,237Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,675——48,926Jan 15, 2026Jan 20, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
19,350——19,350Jan 2, 2026Jan 5, 2026 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
7,203$61.42$442.4K51,507Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
19,658——0Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
12,455$60.46$753.0K58,710Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
19,658$53.77$1.06M71,165Sep 3, 2025Sep 4, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
9,549$42.80$408.7K51,507Aug 4, 2025Aug 5, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
1,484$32.20$47.8K61,056Jan 31, 2025Feb 3, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,032——62,540Jan 30, 2025Feb 3, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
6,523$32.79$213.9K58,508Jan 16, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
22,000——65,437Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
33,000——78,308Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
17,372——65,031Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
17,372——60,936Jan 15, 2025Jan 17, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
22,000——22,000Jan 2, 2025Jan 3, 2025 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
2,071$49.59$102.7K49,812Feb 2, 2024Feb 2, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
2,106$49.59$104.4K47,659Feb 2, 2024Sep 4, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,033——51,883Feb 1, 2024Feb 2, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
5,482$50.42$276.4K47,850Jan 17, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
15,162——53,332Jan 16, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
15,162——45,308Jan 16, 2024Jan 18, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
17,000——43,437Jan 15, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
20,400——60,470Jan 15, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
8,000$53.50$428.0K38,170Jan 12, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
8,000——24,265Jan 12, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
8,000$32.60$260.8K46,170Jan 12, 2024Jan 17, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
27,200——27,200Jan 2, 2024Jan 4, 2024 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
25,000$47.34$1.18M61,052Dec 26, 2023Dec 28, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
25,000——0Dec 26, 2023Dec 28, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
25,000$51.46$1.29M36,052Dec 26, 2023Dec 28, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
1,413$40.67$57.5K24,946Feb 6, 2023Feb 7, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,033——26,359Feb 3, 2023Feb 7, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
4,752$39.57$188.1K22,326Jan 18, 2023Jan 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
13,046——27,078Jan 17, 2023Jan 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
13,046——40,070Jan 17, 2023Jan 19, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
17,207——53,116Jan 15, 2023Jan 18, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
14,338——26,437Jan 15, 2023Jan 18, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
22,942——22,942Jan 3, 2023Jan 4, 2023 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Ofcr
416——14,176Oct 17, 2022Oct 18, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
144$46.52$6.7K14,032Oct 17, 2022Oct 18, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Ofcr
416——35,909Oct 17, 2022Oct 18, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Offc
3,815$30.12$114.9K13,760Jan 18, 2022Jan 20, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Offc
10,400——36,325Jan 18, 2022Jan 20, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Offc
10,400——17,575Jan 18, 2022Jan 20, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,099——12,099Jan 15, 2022Jan 19, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
16,133——46,725Jan 15, 2022Jan 19, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
32,265——32,265Jan 3, 2022Jan 5, 2022 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Offc
417——7,320Oct 15, 2021Oct 19, 2021 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Offc
145$35.10$5.1K7,175Oct 15, 2021Oct 19, 2021 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Offc
417——30,592Oct 15, 2021Oct 19, 2021 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASE
EVP, Chf Clinical Develop Offc
7,503——9,621Jan 15, 2021Jan 20, 2021 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Offc
7,503——15,256Jan 15, 2021Jan 20, 2021 ↗View →
IONS
IONIS PHARMACEUTICALS INC
SALE
EVP, Chf Clinical Develop Offc
2,718$61.28$166.6K6,903Jan 15, 2021Jan 20, 2021 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,753——15,753Jan 15, 2021Jan 20, 2021 ↗View →
IONS
IONIS PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
35,444——35,444Jan 4, 2021Jan 6, 2021 ↗View →
Other insiders · IONS
Loading peer insiders…
About this filer
CIK 0001838539
ROLE
EVP, Chf Clinical Develop Ofcr
PRIMARY
IONS
COMPANIES
1
ACTIVE SINCE
Jan 2021
MARKETPEEL · /INSIDER/0001838539DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback